A case of interleukin-6-producing malignant fibrous histiocytoma originating in the heart

Japanese Journal of Clinical Oncology

Volumn 29, Issue 8, 1999, Pages 382-386

  Deguchi, Hitoshi ^a   Sato, Bunzo ^a   Ohshima, Masato ^a   Seki, Asao ^a   Yamamoto, Masahiro ^a   Naito, Hiroshi ^b   Nishida, Naoki ^c   Yutani, Chikao ^c   Kitamura, Soichiro ^c  

^a Nippon Life Saiseikai Foundation   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Disseminated intravascular coagulation; Interleukin 6; Malignant fibrous histiocytoma; Primary cardiac tumor

Indexed keywords

INTERLEUKIN 6;

AGED; ARTICLE; BIOSYNTHESIS; CASE REPORT; DERMATOFIBROMA; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEART TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; PATHOLOGY;

AGED; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEART NEOPLASMS; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6;

EID: 0033175087     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.8.382     Document Type: Article

References (21)

1. Burke A, Virmani R. Tumors of the Heart and Great Vessels, Atlas of Tumor Pathology, Third Series, Fascicle 16. Washington, DC: Armed Forces Institute of Pathology 1996; 7-11, 142-5.
2. Enzinger FM, Weiss SW. Soft Tissue Tumors, 3rd ed. St. Louis: Mosby 1995;351-80.
3. Tamir G, Nobel M, Hauben DJ, Sandbank J. Malignant fibrous histiocytoma of the breast. Eur J Surg Oncol 1995;21:210-1.
4. Biennann CW, Schnabel R, de Riese W, Schulze H, Senge T. Diagnosis and therapy of primary malignant fibrous histiocytoma of the kidney. Swiss Surg 1995;6:291-3.
5. Wahba A, Liebold A, Birnbaum DE. Recurrent malignant fibrous histiocytoma of the left atrium in a 27-year-old male. Eur J Cardiothorac Surg 1993;7:387-9.
6. Suzuki Y, Ikeda H, Kanemaki K, Seki T, Kondo M, Hara K et al. An autopsy report of malignant fibrous histiocytoma of the left atrium and a review of the pertinent literature. Gan No Rinsho 1990;36:169-75 (in Japanese).
7. Okita Y, Miki S, Ueda Y, Tahata T, Sakai T, Matsuyama K. Recurrent malignant fibrous histiocytoma of the left atrium with extracardiac extension. Am Heart J 1994;127:1624-8.
8. Teramoto N, Hayashi K, Miyatani K, Miyake K, Sarker AB, Tadashi Y, et al. Malignant fibrous histiocytoma of the right ventricle of the heart. Pathol Int 1995;45:315-9.
9. Fang CY, Fu M, Chang JP, Eng HL, Hung JS. Malignant fibrous histiocytoma of the left ventricle:a case report. Chang Keng I Hsueh 1996;19:187-90.
10. Seino Y, Ikeda U, Shimada K. Increased expression of interleukin 6 mRNA in cardiac myxomas. Br Heart J 1993;69:565-7.
11. Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun 1992;5(Suppl A): 123-32.
12. Takemura M, Seishima M, Saito K, Noma A, Shinoda J, Sato M, Kasai C. Evaluation of interleukin-6 (IL-6) measurement by highly sensitive chemiluminescent enzyme immunoassay. Jpn J Med Pharm Sci 1996;36:1071-6 (in Japanese).
13. Klaus R. Cardiac myxomas. N Engl J Med 1995;333:1610-7.
14. Fisher J. Cardiac myxoma. Cardiovasc Rev Rep 1983;9:1195-9.
15. Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum 1990;33:398-402.
16. Kuroki S, Naitoh K, Katoh O, Yamada H, Itoh T. Increased interleukin-6 activity in cardiac myxoma with mediastinal lymphadenopathy. Intern Med 1992;31:1207-9.
17. Wiedermann CJ, Reinisch N, Fischer-Colbrie R, Vollmar AM, Herold M, Knapp EJ. Proinflammatory cytokines in cardiac myxomas. Intern Med 1992;232:263-5.
18. Kasugai T, Sakurai M, Yutani C, Hirota S, Waki N, Adach S, Kitamura Y. Sequential malignant transformation of cardiac myxoma. Acta Pathol Jpn 1990;40:687-92.
19. Kurihara N, Bertolini D, Sida T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 1990;144:4226-30.
20. Davies KA, Cope AP, Schofield JB, Chu CQ, Mason JC, Krausz T, et al. A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol 1995;99:117-23.
21. Ishimi Y, Miyaura C. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-303.